Stay updated on Oral Voxelotor in Sickle Cell Disease Clinical Trial

Sign up to get notified when there's something new on the Oral Voxelotor in Sickle Cell Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Oral Voxelotor in Sickle Cell Disease Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The record describes a completed Phase 3 voxelotor study for sickle cell disease, including its eligibility criteria, participating locations, interventions, and outcome measures. It also provides study publications, results dates, and protocol and analysis-plan documents.
    Difference
    68%
    Check dated 2026-11-08T13:08:09.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0. The study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T13:22:22.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” in some content. The study record remains unavailable behind a 403 error.
    Difference
    1%
    Check dated 2026-10-25T13:21:52.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1, while the study page still shows a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T14:23:38.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 while the study page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T14:12:01.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page no longer displays a 403 Forbidden error. It now shows the study details content for the record, restoring access to the core information.
    Difference
    0.5%
    Check dated 2026-09-27T18:37:50.000Z thumbnail image

Stay in the know with updates to Oral Voxelotor in Sickle Cell Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Oral Voxelotor in Sickle Cell Disease Clinical Trial page.